Zimmer Income Tax Expense from 2010 to 2025

ZBH Stock  USD 110.38  0.86  0.77%   
Zimmer Biomet's Income Tax Expense is decreasing with very volatile movements from year to year. Income Tax Expense is predicted to flatten to about 68.3 M. For the period between 2010 and 2025, Zimmer Biomet, Income Tax Expense quarterly trend regression had mean deviation of  214,421,574 and range of 1.6 B. View All Fundamentals
 
Income Tax Expense  
First Reported
2000-03-31
Previous Quarter
-18.9 M
Current Value
48.9 M
Quarterly Volatility
149.4 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Zimmer Biomet financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zimmer Biomet's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1 B, Interest Expense of 145.1 M or Selling General Administrative of 2.1 B, as well as many indicators such as Price To Sales Ratio of 4.46, Dividend Yield of 0.0153 or PTB Ratio of 1.63. Zimmer financial statements analysis is a perfect complement when working with Zimmer Biomet Valuation or Volatility modules.
  
Check out the analysis of Zimmer Biomet Correlation against competitors.

Latest Zimmer Biomet's Income Tax Expense Growth Pattern

Below is the plot of the Income Tax Expense of Zimmer Biomet Holdings over the last few years. It is Zimmer Biomet's Income Tax Expense historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Zimmer Biomet's overall financial position and show how it may be relating to other accounts over time.
Income Tax Expense10 Years Trend
Very volatile
   Income Tax Expense   
       Timeline  

Zimmer Income Tax Expense Regression Statistics

Arithmetic Mean(10,881,852)
Geometric Mean129,781,854
Coefficient Of Variation(3,509)
Mean Deviation214,421,574
Median100,000,000
Standard Deviation381,830,189
Sample Variance145794.3T
Range1.6B
R-Value(0.1)
Mean Square Error154650.7T
R-Squared0.01
Significance0.71
Slope(8,008,301)
Total Sum of Squares2186914.4T

Zimmer Income Tax Expense History

202568.3 M
2024131.4 M
202342.2 M
2022112.3 M
202153.5 M
2020-137 M
2019-225.7 M

About Zimmer Biomet Financial Statements

Investors use fundamental indicators, such as Zimmer Biomet's Income Tax Expense, to determine how well the company is positioned to perform in the future. Although Zimmer Biomet's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Income Tax Expense131.4 M68.3 M

Currently Active Assets on Macroaxis

When determining whether Zimmer Biomet Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zimmer Biomet's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zimmer Biomet Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zimmer Biomet Holdings Stock:
Check out the analysis of Zimmer Biomet Correlation against competitors.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zimmer Biomet. If investors know Zimmer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zimmer Biomet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.41)
Dividend Share
0.96
Earnings Share
4.43
Revenue Per Share
37.807
Quarterly Revenue Growth
0.043
The market value of Zimmer Biomet Holdings is measured differently than its book value, which is the value of Zimmer that is recorded on the company's balance sheet. Investors also form their own opinion of Zimmer Biomet's value that differs from its market value or its book value, called intrinsic value, which is Zimmer Biomet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zimmer Biomet's market value can be influenced by many factors that don't directly affect Zimmer Biomet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zimmer Biomet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zimmer Biomet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zimmer Biomet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.